Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$56,053,061
-$1,313,406 QoQ
Shares Held
222,751
-15.5% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.96%
of 13F equity value
Holder Rank
#346
of 4,176 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Allworth Financial LP holds $318,890,544 across 18 Drug Manufacturers - General names. ABBV ranks #3 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
362,958 | $92,180,442 | |
| 2 | LLY |
ELI LILLY & Co
|
68,037 | $81,605,624 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
222,751 | $56,053,061 | |
| 4 | MRK |
Merck & Co., Inc.
|
208,546 | $26,798,161 | |
| 5 | AMGN |
Amgen Inc
|
53,858 | $19,503,058 | |
| 6 | NVS |
Novartis AG
|
92,390 | $14,479,360 | |
| 7 | PFE |
Pfizer Inc
|
360,280 | $8,675,542 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
129,525 | $7,463,230 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,053,061 | 222,751 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $57,366,467 | 263,766 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $60,368,428 | 264,206 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $56,457,324 | 243,834 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $39,668,850 | 213,710 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $31,223,718 | 149,025 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $25,592,176 | 144,019 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $17,092,091 | 86,551 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $8,280,642 | 48,278 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $6,708,381 | 36,839 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $4,683,193 | 30,220 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $4,313,051 | 28,935 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $3,390,749 | 25,167 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $4,228,722 | 26,534 | Shares | Sole | 2023-04-18 | |
| 2022-09-30 | $2,740,165 | 20,417 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,761,474 | 18,030 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $2,746,467 | 16,942 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $1,137,901 | 8,404 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $791,442 | 7,337 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $675,389 | 5,996 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,122,133 | 10,369 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $1,066,892 | 9,957 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $883,169 | 10,083 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $1,013,119 | 10,319 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $730,281 | 9,585 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||